✦ LIBER ✦

AT-1 receptor antagonism with candesartan cilexitil improves endothelial function in patients with hypertension and coronary artery disease: A double-blind, randomized, placebo-controlled trial

✍ Scribed by Pasquale Perrone Filardi; Gregorio Brevetti; Antonio Silvestro; Luigi Corrado; Maria Cafiero; Andrea Petretta; Gianluca Caiazzo; Michele Polimeno; Annamaria Zarrilli; Roberta Camerino; Antonio Maglione; Massimo Chiariello

Book ID: 116208822
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 63 KB
Volume: 18
Category: Article
ISSN: 0895-7061
DOI: 10.1016/j.amjhyper.2005.03.196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of AT1 Receptor Antagonism With

Effects of AT1 Receptor Antagonism With Candesartan on Endothelial Function in Patients With Hypertension and Coronary Artery Disease

✍ Pasquale Perrone-Filardi; Luigi Corrado; Gregorio Brevetti; Antonio Silvestro; S 📂 Article 📅 2009 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 297 KB

Angiotensin II receptor antagonism with

Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: A randomized, double-blind, placebo-controlled study

✍ Francesco Pelliccia; Vincenzo Pasceri; Cinzia Cianfrocca; Cristiana Vitale; Giul 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 379 KB

A randomized double-blind placebo-contro

A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease

✍ J Thambyrajah; M.J Landray; H.J Jones; F.J McGlynn; D.C Wheeler; J.N Townsend 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Rationale and design of a randomized, do

Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study

✍ Kim Fox; Roberto Ferrari; Michal Tendera; Philippe Gabriel Steg; Ian Ford 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Long-term safety and maintenance of clin

Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: Extension phase of a randomized, double-blind, placebo-controlled trial

✍ George Nuki; Barry Bresnihan; Moraye B. Bear; Dorothy McCabe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 3 views